Patents by Inventor Kurt F. Hauser

Kurt F. Hauser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bivalent ligands for the treatment of neurological disorders
    Patent number: 9107954
    Abstract: Bivalent ligands that contain two pharmacophores linked through a spacer, one of which interacts with the ?-opioid receptor (MOR) and the other of which interacts with the co-receptor CC chemokine receptor 5 (CCR5), are used for the treatment of neurological disorders such as those associated with AIDS.
    Type: Grant
    Filed: December 12, 2014
    Date of Patent: August 18, 2015
    Assignee: Virginia Commonwealth University
    Inventors: Yan Zhang, Kurt F. Hauser, Dana E. Selley
  • Bivalent Ligands for the Treatment of Neurological Disorders
    Publication number: 20150157730
    Abstract: Bivalent ligands that contain two pharmacophores linked through a spacer, one of which interacts with the ?-opioid receptor (MOR) and the other of which interacts with the co-receptor CC chemokine receptor 5 (CCR5), are used for the treatment of neurological disorders such as those associated with AIDS.
    Type: Application
    Filed: December 12, 2014
    Publication date: June 11, 2015
    Inventors: Yan Zhang, Kurt F. Hauser, Dana E. Selley
  • Bivalent ligands for the treatment of neurological disorders
    Patent number: 8946254
    Abstract: Bivalent ligands that contain two pharmacophores linked through a spacer, one of which interacts with the ?-opioid receptor (MOR) and the other of which interacts with the co-receptor CC chemokine receptor 5 (CCR5), are used for the treatment of neurological disorders such as those associated with AIDS.
    Type: Grant
    Filed: January 10, 2013
    Date of Patent: February 3, 2015
    Assignee: Virginia Commonwealth University
    Inventors: Yan Zhang, Kurt F. Hauser, Dana E. Selley
  • Bivalent Ligands for the Treatment of Neurological Disorders
    Publication number: 20140357656
    Abstract: Bivalent ligands that contain two pharmacophores linked through a spacer, one of which interacts with the ?-opioid receptor (MOR) and the other of which interacts with the co-receptor CC chemokine receptor 5 (CCR5), are used for the treatment of neurological disorders such as those associated with AIDS.
    Type: Application
    Filed: January 10, 2013
    Publication date: December 4, 2014
    Applicant: Virginia Commonwealth University
    Inventors: Yan Zhang, Kurt F. Hauser, Dana E. Selley